Shivani Garg

Associate Professor

University of Wisconsin-Madison

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Shivani Garg is an Associate Professor at the University of Wisconsin–Madison in the United States. Her research primarily focuses on lupus nephritis and systemic lupus erythematosus, exploring areas such as medication adherence, health disparities, and the associations of various health determinants with patient outcomes. Recent articles authored by Dr. Garg examine the impact of therapeutic levels of hydroxychloroquine and the relationship between inflammatory markers and vascular changes in lupus patients.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (5)

Christie M Bartels

Division Head, Associate Professor (tenured)

University of Wisconsin School of Medicine and Public Health

UNITED STATES

View details

Rosalind Ramsey‐Goldman

UNITED STATES

View details

Brad H Rovin

The Ohio State University Wexner Medical Center

UNITED STATES

View details

Arezou Khosroshahi

Associate Professor of Medicine

Emory University

UNITED STATES

View details

Daniel Montes

Assistant Professor

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shivani Garg

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Hydroxychloroquine Associated with Lower Glomerular Filtration Rate Decline in Lupus Nephritis

Associations of retention in care by visits or lupus-specific labs with acute care among young adults: A medicare cohort study

Comment on: Renal arteriosclerosis in kidney biopsies associated with higher 10-year atherosclerotic cardiovascular disease in lupus nephritis: Reply

Renal arteriosclerosis in kidney biopsies associated with higher 10-year atherosclerotic cardiovascular disease in lupus nephritis

Intermediate monocytes in blood correlate with subclinical vascular changes in lupus nephritis

Multiplicative Impact of Adverse Social Determinants of Health on Outcomes in Lupus Nephritis: A Meta-analysis and Systematic Review.

Development of the American College of Rheumatology's Patient-reported Outcome Quality Measures for Systemic Lupus Erythematosus.

Therapeutic Hydroxychloroquine Blood Levels Are Associated With Fewer Hospitalizations and Possible Reduction of Health Disparities in Lupus

A Bitter Pill to Swallow: The Challenge of Medication Nonadherence in Systemic Lupus Erythematosus

Reference Range of Hydroxychloroquine Blood Levels That Can Reduce Odds of Active Lupus and Prevent Flares

Collaborators (5)

Christie M Bartels

Rosalind Ramsey‐Goldman

Brad H Rovin

Arezou Khosroshahi

Daniel Montes

Make your next move.